14 Feb Peania, February 14th, 2020
Posted at 17:02h
in Announcements, Announcements 2020, Press Releases, Press Releases 2020, Regulated Information
Peania, February 14th, 2020 – Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.’s Executive Chairman, Dr. Athanase Lavidas, proceeded with the following stock purchase : on 12/02/2020 purchased 5 Lavipharm S.A. common registered shares amounting to € 1,35, on 13/02/2020 40.000 Lavipharm S.A. common registered shares amounting to € 11.600, and on 14/02/2020 40.000 Lavipharm S.A. common registered shares amounting to € 11.600